David J. Mazzo - Jan 10, 2022 Form 4 Insider Report for CALADRIUS BIOSCIENCES, INC. (LSTA)

Role: Chief Executive Officer, Director
Signature: David J. Mazzo, by: /s/ Todd C. Girolamo, Esq., Attorney-in-Fact
Stock symbol: LSTA
Transactions as of: Jan 10, 2022
Transactions value $: -$66,210
Form type: 4
Date filed: 1/12/2022, 03:21 PM
Next filing: Jan 18, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LSTA	Common Stock	Award	$0	+401K	+126.78%	$0.00	717K	Jan 10, 2022	Direct	F1, F2
transaction	LSTA	Common Stock	Tax liability	-$51.7K	-56.4K	-7.86%	$0.92	661K	Jan 10, 2022	Direct	F2, F3
transaction	LSTA	Common Stock	Tax liability	-$14.5K	-16.7K	-2.53%	$0.87	644K	Jan 11, 2022	Direct	F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LSTA	Stock Option (Right to Buy)	Award	$0	+200K		$0.00	200K	Jan 10, 2022	Common Stock	200K	$0.92	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents 401,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
F2	Includes 424,750 unvested restricted stock.
F3	Shares withheld as payment of a tax liability on vesting of restricted stock.
F4	Includes 395,000 unvested restricted stock.
F5	One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.